[Combined chemotherapy of disseminated skin melanoma]. 1978

N P Dement'eva, and E K Voznyĭ, and L A Koroleva

The author's experience with nitrosomethylurea+prospidine treatment in 37 patients having disseminated melanoma is described. The mentioned scheme of the combination therapy is proved to be effective.

UI MeSH Term Description Entries
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D008770 Methylnitrosourea A nitrosourea compound with alkylating, carcinogenic, and mutagenic properties. Nitrosomethylurea,N-Methyl-N-nitrosourea,NSC-23909,N Methyl N nitrosourea,NSC 23909,NSC23909
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009362 Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D009607 Nitrosourea Compounds A class of compounds in which the core molecule is R-NO, where R is UREA. Compounds, Nitrosourea
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D011447 Prospidium An antineoplastic dispiropiperazine derivative. Prospidin,Prospidine,Prospidium Chloride,Chloride, Prospidium
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females

Related Publications

N P Dement'eva, and E K Voznyĭ, and L A Koroleva
January 1986, Archiv fur Geschwulstforschung,
N P Dement'eva, and E K Voznyĭ, and L A Koroleva
September 1978, La Nouvelle presse medicale,
N P Dement'eva, and E K Voznyĭ, and L A Koroleva
January 1990, Sovetskaia meditsina,
N P Dement'eva, and E K Voznyĭ, and L A Koroleva
April 1967, The Ohio State medical journal,
N P Dement'eva, and E K Voznyĭ, and L A Koroleva
June 1972, Cancer,
N P Dement'eva, and E K Voznyĭ, and L A Koroleva
February 1975, Cancer,
N P Dement'eva, and E K Voznyĭ, and L A Koroleva
August 1995, Anti-cancer drugs,
N P Dement'eva, and E K Voznyĭ, and L A Koroleva
January 1987, Sovetskaia meditsina,
N P Dement'eva, and E K Voznyĭ, and L A Koroleva
January 1981, Voprosy onkologii,
Copied contents to your clipboard!